Self-Expanding Versus Balloon Expanding Coronary Stents in Intervention of the Degenerated Saphenous Vein Graft: Memmingen Coronary Artery Bypass Stenosis Trial (MECAST)

Table 3

Outcome.

	SExS (n = 51)		BExS (n = 56)		value
	n SD	n (%)	n SD	n (%)
MACE 30 days	11.00	2.0	7	12.5	0.039
MACE 12 months	8	15.7	204.03	35.7	0.019
Cardiac death	52.18	9.8	7	12.5	0.660
MI	11.00	2.0	103.01	17.9	0.007
TLR	11.00	2.0	113.14	19.6	0.004
TVR	3	5.9	133.38	23.2	0.012
Stent thrombosis (possible + definite)	11.00	2.0	7	12.5	0.039

Values are number (n)standard deviation (SD) or number (%). A value<0.05 is considered significant. SExS = self-expanding drug eluting stent; BExS = balloon expanding drug eluting stent; MACE = major adverse cardiac event; MI = myocardial infarction; TLR = target lesion revascularization; and TVR = target vessel revascularization.